Routine glaucoma screening program may benefit middle-age African-American patients

March 12, 2012

Implementing a routine national glaucoma screening program for middle-age African American patients may be clinically effective; however its potential effect on reducing visual impairment and blindness may be modest, according to a computer-based mathematical model reported in the March issue of Archives of Ophthalmology.

"Primary open-angle is a chronic, degenerative disease that affects more than 2.2 million Americans and 1.9 percent of Americans older than 40 years," the authors write as background in the study. "The high prevalence of undiagnosed glaucoma contributes to visual loss, an outcome that is disproportionately common in African American individuals, where as many as 11 percent of elderly patients develop blindness."

Using data from the Eye Diseases Prevalence Research Group and Baltimore Eye Study, Joseph A. Ladapo, M.D., Ph.D., then of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, now with NYU Langone Medical Center, New York, and colleagues developed a microsimulation computer-based model to project visual outcomes among African American individuals screened for glaucoma under a national .

Based on the developed , the authors found that a universal, community-based glaucoma screening program for African American patients is potentially clinically effective; however, its overall potential effect on visual impairment and blindness appears relatively modest. The authors predict that a glaucoma for between the ages of 50 and 59 years without known glaucoma would reduce the lifetime prevalence of undiagnosed glaucoma from 50 percent to 27 percent, the prevalence of glaucoma-related visual impairment from 4.6 percent to 4.4 percent, and would reduce the prevalence of glaucoma-related blindness from 6.1 percent to 5.6 percent.

The projected cost as outlined by the authors would be $80 per individual screened, considering only the cost of frequency-doubling technology and eye examinations to confirm the diagnosis. The number of patients needed to screen to diagnose one person with glaucoma was estimated at 58, and the number needed to screen to prevent one person from developing visual impairment was estimated at 875. The authors also note that they did not consider "the cost of visual rehabilitation, disability or long-term care in patients with blindness, which are substantial."

"We conclude that routine screening for glaucoma in African American individuals is a potentially clinically effective and economical method to reduce the burden of glaucoma-related visual impairment and blindness, though its absolute benefit is likely to be modest," the authors write. "Future studies should also consider long-term costs associated with treatment and the impact of delaying on health-related quality of life."

Explore further: Research identifies risk factors associated with progression of glaucoma

More information: Arch Ophthalmol. 2012;130[3]:365-372.

Related Stories

Research identifies risk factors associated with progression of glaucoma

May 9, 2011
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology.

Expenditures for glaucoma medications appear to have increased

June 13, 2011
In recent years, spending for glaucoma medications has increased, especially for women, persons who have only public health insurance and those with less than a high school education, according to a report published Online ...

Recommended for you

Simulations signal early success for fractal-based retinal implants

July 27, 2017
Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing.

Scientists regenerate retinal cells in mice

July 26, 2017
Scientists have successfully regenerated cells in the retina of adult mice at the University of Washington School of Medicine in Seattle.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.